A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples

被引:76
作者
Chin, SF
Daigo, Y
Huang, HE
Iyer, NG
Callagy, G
Kranjac, T
Gonzalez, M
Sangan, T
Earl, H
Caldas, C
机构
[1] Addenbrookes Hosp, Hutchison MRC Res Ctr, Ccanc Genom Program, Dept Oncol, Cambridge CB2 2XZ, England
[2] Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo 1088639, Japan
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2003年 / 56卷 / 05期
关键词
D O I
10.1136/mp.56.5.275
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To describe a robust pretreatment protocol for preparing paraffin wax embedded tissues on tissue microarrays for fluorescence in situ hybridisation (FISH). The newly developed pretreatment protocol described here was compared with the commonly used sodium thiocyanate based protocol and two different heating methods used in standard antigen unmasking protocols for immunohistochemistry (pressure cooking and microwaving in citrate acid buffer). Methods: Dewaxed tissue sections were incubated in 10mM citric acid buffer at 80degreesC for 30 minutes to two hours, followed by a short pepsin digestion (1-5 mg/ml). Pretreated tissues were co-denatured with DNA probes at 80degreesC for 10 minutes, followed by hybridisation at 37degreesC for 48-72 hours. Results: The three protocols using citrate acid buffer produced FISH signals with superior signal to noise ratios compared with sodium thiocyanate pretreatment. Most importantly, the best tissue attachment was achieved using the newly developed pretreatment protocol: on tissue microarrays less than 1 % of cores were lost. To date, a total of 30 probes have been successfully hybridised on to breast tissue and multi-tissue microarrays. Conclusion: This pretreatment protocol is easy, reproducible, and facilitates FISH on tissue microarrays, with potential for widespread application in cancer research.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 21 条
[1]   The clinical evaluation of HER-2 status: which test to use? [J].
Bartlett, J ;
Mallon, E ;
Cooke, T .
JOURNAL OF PATHOLOGY, 2003, 199 (04) :411-417
[2]   Fusion genes in leukemia: an emerging network [J].
Bohlander, SK .
CYTOGENETICS AND CELL GENETICS, 2000, 91 (1-4) :52-56
[3]   Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies [J].
Bubendorf, L ;
Nocito, A ;
Moch, H ;
Sauter, G .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :72-79
[4]   Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres [J].
Dowsett, M ;
Bartlett, J ;
Ellis, IO ;
Salter, J ;
Hills, M ;
Mallon, E ;
Watters, AD ;
Cooke, T ;
Paish, C ;
Wencyk, PM ;
Pinder, SE .
JOURNAL OF PATHOLOGY, 2003, 199 (04) :418-423
[5]  
Fletcher JA, 1999, AM J CLIN PATHOL, V112, pS11
[6]   FORMATION AND DETECTION OF RNA-DNA HYBRID MOLECULES IN CYTOLOGICAL PREPARATIONS [J].
GALL, JG ;
PARDUE, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1969, 63 (02) :378-&
[7]   FLUORESCENCE IN-SITU HYBRIDIZATION IN CANCER AND RADIATION BIOLOGY [J].
GRAY, JW ;
PINKEL, D ;
BROWN, JM .
RADIATION RESEARCH, 1994, 137 (03) :275-289
[8]  
HOPMAN AHN, 1991, MODERN PATHOL, V4, P503
[9]   Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers [J].
Janocko, LE ;
Brown, KA ;
Smith, CA ;
Gu, LP ;
Pollice, AA ;
Singh, SG ;
Julian, T ;
Wolmark, N ;
Sweeney, L ;
Silverman, JF ;
Shackney, SE .
CYTOMETRY, 2001, 46 (03) :136-149
[10]   RNA-DNA HYBRIDS AT CYTOLOGICAL LEVEL [J].
JOHN, HA ;
BIRNSTIE.ML ;
JONES, KW .
NATURE, 1969, 223 (5206) :582-+